NCT00071994View on ClinicalTrials.gov

Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2005

Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Interventions
DRUG

gefitinib

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00071994 - Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) | Biotech Hunter | Biotech Hunter